ClinicalTrials.govpublic full text
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease
alzheimer's disease, alzheimer disease, brain diseases, dementia, neurodegenerative diseases, neurocognitive disorders, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892500
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.